These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17307628)

  • 1. Isolated atomoxetine overdose resulting in seizure.
    Kashani J; Ruha AM
    J Emerg Med; 2007 Feb; 32(2):175-8. PubMed ID: 17307628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated atomoxetine (Strattera) ingestions commonly result in toxicity.
    Lovecchio F; Kashani J
    J Emerg Med; 2006 Oct; 31(3):267-8. PubMed ID: 16982359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine ingestions in children: a report from poison centers.
    Spiller HA; Lintner CP; Winter ML
    Ann Pharmacother; 2005 Jun; 39(6):1045-8. PubMed ID: 15870137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmortem tissue distribution of atomoxetine following fatal and nonfatal doses--three case reports.
    Garside D; Ropero-Miller JD; Riemer EC
    J Forensic Sci; 2006 Jan; 51(1):179-82. PubMed ID: 16423247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
    Wernicke JF; Holdridge KC; Jin L; Edison T; Zhang S; Bangs ME; Allen AJ; Ball S; Dunn D
    Dev Med Child Neurol; 2007 Jul; 49(7):498-502. PubMed ID: 17593120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Wang Y; Zheng Y; Du Y; Song DH; Shin YJ; Cho SC; Kim BN; Ahn DH; Marquez-Caraveo ME; Gao H; Williams DW; Levine LR
    Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined overdose of atomoxetine and methylphenidate in a cytochrome P450 2D6 poor metabolizer.
    Reimers A; Langsetmo HK
    J Clin Psychopharmacol; 2007 Feb; 27(1):110-1. PubMed ID: 17224704
    [No Abstract]   [Full Text] [Related]  

  • 10. Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate.
    Cole JB; Stellpflug SJ; Gross EA; Smith SW
    Pediatr Emerg Care; 2011 Dec; 27(12):1175-7. PubMed ID: 22158278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskinesias associated with atomoxetine in combination with other psychoactive drugs.
    Bond GR; Garro AC; Gilbert DL
    Clin Toxicol (Phila); 2007; 45(2):182-5. PubMed ID: 17364639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS; Aparasu RR
    Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status epilepticus following intentional overdose of fluvoxamine: a case report with serum fluvoxamine concentration.
    Wood DM; Rajalingam Y; Greene SL; Morgan PE; Gerrie D; Jones AL; Dargan PI
    Clin Toxicol (Phila); 2007; 45(7):791. PubMed ID: 17952747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH; Kratochvil CJ; Allen AJ; Casat CD; Ruff DD; Moore RJ; Michelson D;
    Am J Psychiatry; 2008 Jun; 165(6):721-30. PubMed ID: 18281409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
    Wilens TE; Adler LA; Weiss MD; Michelson D; Ramsey JL; Moore RJ; Renard D; Brady KT; Trzepacz PT; Schuh LM; Ahrbecker LM; Levine LR;
    Drug Alcohol Depend; 2008 Jul; 96(1-2):145-54. PubMed ID: 18403134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report.
    Chua-Tuan JL; Cao D; Iwanicki JL; Hoyte CO
    Clin Toxicol (Phila); 2015 Jul; 53(6):565-8. PubMed ID: 25951877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension.
    Minns AB; Clark RF; Schneir A
    Clin Toxicol (Phila); 2010 Feb; 48(2):146-8. PubMed ID: 20136479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdose of propafenone surreptitiously sold as "Percocet".
    D'Orazio JL; Curtis JA
    J Emerg Med; 2011 Aug; 41(2):172-5. PubMed ID: 20456902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.
    Block SL; Kelsey D; Coury D; Lewis D; Quintana H; Sutton V; Schuh K; Allen AJ; Sumner C
    Clin Pediatr (Phila); 2009 Sep; 48(7):723-33. PubMed ID: 19420182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.